Details of the Drug

General Information of Drug (ID: DMW2GEJ)

Drug Name

Mepolizumab

Synonyms

Bosatria; Scoparianoside C; SB 240563; Immunoglobulin G1, anti-(human interleukin 5) (human-mouse monoclonal SB-240563 gamma1-chain), disulfide with human-mouse monoclonal SB-240563 kappa-chain, dimer; (2S,3S,4S,5R,6R)-6-[[(3S,4aR,6aR,6bS,8aS,14aR,14bR)-8a-carboxy-4,4,6a,6b,11,11,14b-heptamethyl-1,2,3,4a,5,6,7,8,9,10,12,13,14,14a-tetradecahydropicen-3-yl]oxy]-3,5-dihydroxy-4-[(2S,3R,4S,5R)-3,4,5-trihydroxyoxan-2-yl]oxyoxane-2-carboxylic acid

Indication

Disease Entry	ICD 11	Status	REF
Severe asthma	CA23	Approved	[1]
Asthma	CA23	Phase 2/3	[2]
------------------------------------------------------------------------------------

Affected Organisms

Humans and other mammals

Drug Type

Monoclonal antibody

ADMET Property

Absorption Tmax: The time to maximum plasma concentration (Tmax) is 30-60 min [3]
Bioavailability: The bioavailability of drug is 100% [3]
Clearance: The sytemic clearance of drug is 0.28 L/day [4]
Half-life: The concentration or amount of drug in body reduced by one-half in 16 - 22 days [4]
Metabolism: The drug is metabolized via proteolytic degradation at sites distributed throughout the body [4]
Vd: The volume of distribution (Vd) of drug is 3.6 L [4]

Cross-matching ID

UNII: 90Z2UF0E52
DrugBank ID: DB06612
TTD ID: D03MTN

Repurposed Drugs (RPD)

Click to Jump to the Detailed RPD Information of This Drug

Molecular Interaction Atlas of This Drug

Drug Therapeutic Target (DTT)

DTT Name	DTT ID	UniProt ID	MOA	REF
Interleukin-5 (IL5)	TTPREZD	IL5_HUMAN	Modulator	[5]

------------------------------------------------------------------------------------

Molecular Interaction Atlas (MIA)

MIA Detail

Jump to Detail Molecular Interaction Atlas of This Drug

Molecular Expression Atlas of This Drug

The Studied Disease

Severe asthma

ICD Disease Classification

CA23

Molecule Name	Molecule Type	Gene Name	p-value	Fold-Change	Z-score
Interleukin-5 (IL5)	DTT	IL5	6.51E-01	-0.02	-0.11
Interleukin-5 (IL5)	DTT	IL5	1.71E-04	0.12	0.71

Molecular Expression Atlas (MEA)

MEA Detail

Jump to Detail Molecular Expression Atlas of This Drug

References

1	URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7685).
2	ClinicalTrials.gov (NCT01366521) Dose Ranging Pharmacokinetics and Pharmacodynamics Study With Mepolizumab in Asthma Patients With Elevated Eosinophils
3	FDA Approved Drug Products: Monoket (isosorbide mononitrate) tablets
4	FDA Approved Drug Products: Nucala (mepolizumab) injection
5	Mepolizumab: 240563, anti-IL-5 monoclonal antibody - GlaxoSmithKline, anti-interleukin-5 monoclonal antibody - GlaxoSmithKline, SB 240563. Drugs R D. 2008;9(2):125-30.